Rebecca Taub

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Venues

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Stephen A Harrison, Rebecca Taub
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. Reply. The New England journal of medicine 390 (17) (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Stephen A Harrison, Rebecca Taub
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. Reply. The New England journal of medicine 390 (17) (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Stephen A Harrison, Rebecca Taub
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. Reply. The New England journal of medicine 390 (17) (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)

Rebecca Taub.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rebecca Taub